logo
People with disabilities set to receive new $200 monthly benefit

People with disabilities set to receive new $200 monthly benefit

Yahoo5 days ago
People who qualify for the new Canada Disability Benefit will begin receiving their payments this month.
Haley Flaro, the executive director of Ability New Brunswick, is relieved they won't face reduced disability payments from the province as a result. Under the new benefit, eligible recipients can receive up to $200 per month or $2,400 a year.
Flaro says Alberta is going to claw back from the benefits people already receive in that province.
"They've decided to take it, claw it back from their social assistance benefits, which isn't going to help people move towards lifting them out of poverty," Flaro said.
"It's actually going to be a way to subsidize their own social assistance system, which is really unfortunate."
There was a fear that other provinces would follow Alberta's lead, but not New Brunswick says Social Development Minister Cindy Miles.
"It's more important than ever that our most vulnerable residents feel secure and supported," Miles said in a release. "I want to make it clear to New Brunswickers who receive disability benefits that receiving the Canadian Disability Benefit will not reduce their payments from the department."
Flaro says New Brunswick's commitment honours the spirit of what they're trying to achieve..
"It was really intended to help lift people with a disability out of poverty in New Brunswick," she said. "They're one of the two most impoverished populations, next only to single mothers."
According to the most recent data from Statistics Canada, 35.3 per cent of New Brunswickers are living with a disability, the second-highest rate in Canada.
The national average is 27 per cent.
When the federal government announced the new benefit early last year, advocates like Flaro were disappointed by the low amount. They didn't think it would make a significant difference.
Flaro told CBC at the time that they were expecting something closer to $2,000 a month.
Now that the program is in place and payments are set to begin, Flaro says the organization wants to work with the government to make it more generous.
"It's certainly not the amount that people with disabilities were looking for, nor organizations like ours, but there's a lot of infrastructure and planning that goes into this type of benefit and it's in place now and there's nowhere to go but up," Flaro said.
Even though the amount is lower than what was sought, Flaro says it will make a huge difference for people facing rising costs in housing, food and power rates.
People with disabilities also face added costs for things like home support services, medications and transportation.
"We're facing many crises in New Brunswick and throughout Canada," she said. "This is going to be $2,400 a year helping people address their basic needs."
Flaro says the provincial government is open to talking about an income program that would pay a "living wage" to people with disabilities in need, something more like what they pressed Ottawa for in consultations last year.
She says the new Canada Disability Benefit is a step in that direction.
"This is a significant victory in New Brunswick," she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Novo Nordisk A/S (NVO): 'Canada's A Backdoor,' Says Jim Cramer
Novo Nordisk A/S (NVO): 'Canada's A Backdoor,' Says Jim Cramer

Yahoo

time6 hours ago

  • Yahoo

Novo Nordisk A/S (NVO): 'Canada's A Backdoor,' Says Jim Cramer

We recently published . Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer recently discussed. Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical company that was one of the earliest movers in the weight loss drug market. The shares have lost 21% year-to-date due to multiple headwinds. These include investor worries about the firm lagging behind US pharma giant Eli Lilly in the weight loss drug market, the surprise departure of its CEO, and troubles with its CagriSema weight loss drug's trial. Cramer's previous remarks about Novo Nordisk A/S (NYSE:NVO) have wondered why the firm fell behind Eli Lilly and hoped that activist investor interest in the firm would yield positive results. This time around, he discussed the firm's decision to let its weight loss drug patent expire in Canada: 'By the way, nod there to Brandon Gomez, really, really good piece that Novo Nordisk, did not file, I think it's patent correctly in Canada. And Canada's a backdoor, Hims & Hers is right there.' An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. Cramer's previous remarks about Novo Nordisk A/S (NYSE:NVO) discussed the firm's weight loss drug business and activist investor interest: [On activist fund Parvus building a stake in the company] How could they be so far behind? You know they were first, they were first mover. And then Lilly came along, Lilly by the way, still a great stock. But maybe this is going to shake up Novo. While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Nunavut Premier extends condolences after 3 deaths in Pond Inlet
Nunavut Premier extends condolences after 3 deaths in Pond Inlet

Yahoo

time8 hours ago

  • Yahoo

Nunavut Premier extends condolences after 3 deaths in Pond Inlet

Nunavut Premier P.J. Akeeagok is sharing his sympathies with the community of Pond Inlet, Nunavut, after three recent deaths. "Like many Nunavummiut, I am heartbroken by the tragic events that have shaken your community," Akeeagok said in a statement Saturday. The territory's coroner said Friday that his office is investigating the deaths, but that it would be inappropriate to share details at this point and that the report would become public once completed. Akeeagok said the Nunavut government has mobilized all available resources to those affected. Nunavut government spokesperson Casey Lessard said in an email that health workers and virtual mental health support is already being offered to affected residents. "To the residents of Pond Inlet: please know that the entire territory stands with you," Akeeagok said. "You are not alone. We will walk with you through this tragedy and support your healing in the days and weeks ahead." If you or someone you know in Nunavut is struggling, the following resources may help: Nunavut Kamatsiaqtut Helpline (available 24 hours a day): 979-3333 in Iqaluit, or 1-800-265-3333 Healing by Talking counselling program: 1-888-648-0070 Government of Nunavut Employee and Family Assistance Program: 1-800-663-1142 Isaksimagit Inuusirmi Katujjiqatigiit (Embrace Life Council): 1-866-804-2782 Kids Help Phone: 1-800-668-6868 or text TALK to 686868 Hope for Wellness Helpline: 1-855-242-3310 Victim's Services: 1-866-456-5216 Residential Schools Resolution Health Support Program: 1-800-464-8106

Diabetic Woman No Longer Needs Insulin After Single Dose of Experimental Stem Cells
Diabetic Woman No Longer Needs Insulin After Single Dose of Experimental Stem Cells

Yahoo

time9 hours ago

  • Yahoo

Diabetic Woman No Longer Needs Insulin After Single Dose of Experimental Stem Cells

A Canadian woman with type 1 diabetes spent nearly a decade dependent on her glucose monitor and insulin shots — but after a single dose of manufactured stem cells implanted into her liver, she's now free. In an interview with CTV, 36-year-old Amanda Smith of London, Ontario described how it felt to be part of such a groundbreaking experiment that has allowed her body to once again produce its own insulin. "I remember, like, being scared and excited," Smith said of the study, "and it's history now." Although things are improving for type 1 diabetics, whose pancreases cannot produce their own insulin, the condition still requires ample maintenance and most often results in at least 10 to 12 years being taken off one's life. Diagnosed at 25 with late-onset juvenile diabetes, the woman said that the prognosis for the disease always felt like a "death sentence." "The end is always some sort of complication with diabetes," Smith said. After enrolling in the stem cell study, which is the subject of a new paper in the New England Journal of Medicine, all that changed for the Ontario woman. Smith and 11 other participants on both sides of the border were implanted with special embryonic stem cells, which were altered to grow in the liver and transform into a hormone-producing array of cells that secrete insulin the way a non-diabetic's pancreas does. Of that study cohort, 10 of the 12 stopped needing insulin shots for at least a year — and according to Trevor Reichman, the surgical director of the University Health Network in Toronto's diabetic transplant program and lead author of the paper, the study's "biological replacements" took hold in seconds. "In the liver, they're sensing a patient's blood glucose level, and they're secreting the appropriate hormone," Reichman said of the stem cell implants. "Essentially, it's the same as your native... cells would function." Incredible as these results are, there is a catch: to keep the stem cells working, patients must take immune-suppressing medications so their bodies don't reject the implanted cells — which means they've become more susceptible than most to illness. (Charlbi Dean Kriek, the star of 2022's "Triangle of Sadness," had been on immunosuppressants for a decade following a spleen removal when she died of an infection soon after the film came out.) For Smith, who on August 1 will celebrate her two-year implant-iversary, swapping quality of life for her old insulin shots and the threat of diabetic comas was a no-brainer — even if it means she's more vulnerable to sickness. "Taking a couple of pills three times a day is nothing," she said of her medication regimen. "I take it with breakfast, lunch, and dinner. It's easy." Still, such immunosuppression is no joke. As Reichman told CTV, one of the study cohort patients died, and the culprit may well have been an illness they caught while on said immunosuppressants — which is why the next phase of research will be into stem cell implants that the body won't reject. More on diabetes: RFK Jr. Surprised to Learn He'd Cut a Grant For Youth Diabetes Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store